Cyclist Thomas Peyroton-Dartet Suspended for Positive EPO
The 41-year-old rider faces a provisional suspension following an adverse drug test at the Para-cycling World Championships.
Updated on Oct. 30, 2026 in Cycling
Live Poll
Do you trust that current anti-doping testing protocols in professional sports are effective?
Cyclist Thomas Peyroton-Dartet has been provisionally suspended following a positive test for erythropoietin (EPO). The 41-year-old athlete provided the sample during the 2026 Para-cycling World Championships in Huntsville.
Why it matters
The suspension highlights ongoing efforts by anti-doping bodies to ensure fair competition at international athletic events. The case underscores the rigorous testing protocols currently in place for elite cyclists.
The International Testing Agency reported an adverse analytical finding for erythropoietin following an in-competition sample collection on September 5, 2026. The findings remain subject to verification via a potential B-sample analysis.
The players
International Testing Agency
An independent body that manages anti-doping programs for international sports federations.
Thomas Peyroton-Dartet
A 41-year-old competitive cyclist who participated in the 2026 Para-cycling World Championships.
The details
Erythropoietin is a hormone that stimulates red blood cell production, potentially increasing aerobic capacity and endurance. Anti-doping authorities conduct in-competition screenings to detect synthetic versions of this hormone that provide an unfair physiological advantage. If the B-sample analysis confirms the presence of the substance, or if the rider declines further testing, the case will be officially classified as an anti-doping rule violation.
Timeline
September 5, 2026: Thomas Peyroton-Dartet provided a sample that tested positive for EPO.
September 7, 2026: Thomas Peyroton-Dartet won the C3 road race gold medal.
October 30, 2026: The International Testing Agency announced the positive test result.
Health Landscape
The use of synthetic hormones in professional cycling is strictly regulated under the World Anti-Doping Agency Prohibited List. This incident represents an ongoing effort to maintain the integrity of competitive sports through systematic biological screening.
Readers interested in the physiological effects of blood-boosting hormones should consult with a physician about the serious health risks associated with such substances. These substances can significantly increase the risk of cardiovascular events, including blood clots and stroke.
The takeaway
The use of performance-enhancing drugs poses severe, long-term health risks to the cardiovascular system. It is important to remember that professional athletic integrity relies on adherence to standardized, evidence-based anti-doping regulations.
Further reading
For more on how athletic performance is regulated, visit our Cycling section.
Source note: This article includes information reported by Cyclingnews.
Live Poll
Do you trust that current anti-doping testing protocols in professional sports are effective?
